HaliangiumHaliangium
Compared within studies that had both

In conditions

Compared with healthy people in the same studies, it’s less common in none and more common in 1 condition. Only studies that had both are counted.

A difference is an association: it doesn’t mean this microbe causes, prevents or treats any of these.

Strongest first, then the biggest gap · Each figure is 10 people
  1. Kidney cancer (renal cell carcinoma) 51 people · 1 study More common in people with it Healthy 0% With it 35%

Where these numbers come from

Studies
Only GMrepo projects that had people with the condition and healthy people, 10 or more of each. Numbers come from those studies, never from pooling.
How common
The share of people whose sample has any of it, in the people with the condition and in the healthy people of those same studies. Tested within studies (Cochran–Mantel–Haenszel, corrected for testing many microbes); a difference counts when it is clear and meaningful (Cohen’s h of 0.2 or more).
Strength word
Counted by code from how many studies point the same way: Seen again and again (3 or more, none clearly the other way), Seen more than once (2, the majority), Seen once (1, listed last). Where studies disagree, a row isn’t listed.
Each study
Tap a row for every study’s own numbers, and for how much carriers have.
Analysis
Our analysis of GMrepo data. GMrepo on Data sources · Read the rules

Also compared · 5 conditions

Compared within studies that had both, but not listed above.

Studies disagree · 2

No meaningful difference · 3